The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of tepotinib and immune checkpoint inhibitor therapy for MET exon 14 skipping NSCLC: A multicentric retrospective analysis.
 
Kazuhito Misawa
No Relationships to Disclose
 
Kageaki Watanabe
No Relationships to Disclose
 
Yasuhiro Kato
No Relationships to Disclose
 
Ryota Saito
No Relationships to Disclose
 
Seigo Katakura
No Relationships to Disclose
 
Kazuhiro Nishiyama
No Relationships to Disclose
 
Takayuki Kobayashi
No Relationships to Disclose
 
Kanako Shinada
No Relationships to Disclose
 
Naoki Furuya
No Relationships to Disclose
 
Tetsuya Okano
No Relationships to Disclose
 
Yukio Hosomi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; Kyowa Kirin International; Lilly Japan; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Hideaki Mizutani
No Relationships to Disclose